稳定期转移性乳腺癌患者的乳腺肿瘤经皮冷冻消融:安全性、可行性与疗效
本研究纳入17例因转移性疾病未行手术的原发性乳腺肿瘤女性患者,在疾病稳定期以超声或CT引导行经皮冷冻消融,术前及术后1、3、6、12个月行临床与乳腺MRI评估。所有操作在局部麻醉下技术成功,15例原发灶完全消退且随访无复发,2例病灶40 mm和45 mm者随访复发并另行冷冻消融;5例冷冻前疼痛性肿块者术后即刻缓解并持续整个随访期。作者认为冷冻消融似乎适合转移性患者的姑息治疗。
要点
- 超声或CT引导下经皮冷冻消融可在局部麻醉下完成,本组全部技术成功。
- 15例原发灶完全消退且随访无复发,2例40 mm与45 mm病灶随访复发。
- 5例冷冻前疼痛性肿块术后即刻缓解并持续整个随访期。
核心结论
- 原发乳腺病灶冷冻消融似乎适合转移性患者的姑息治疗,因其耐受性好、并发症率低并能提供局部或镇痛控制。
研究设计与样本
- 研究纳入17例女性患者(平均年龄54.8岁±10.8,范围37-72岁),原发乳腺肿瘤因转移性疾病未行手术,在疾病稳定期以超声或CT引导行经皮冷冻治疗。
关键影像表现/征象
- 原发灶平均最大径16±12 mm(范围5-45 mm)。
- 15例原发乳腺病灶完全消退且随访期无复发。
- 2例病灶分别为40 mm和45 mm者随访期复发,并接受第二次冷冻治疗(未纳入本研究)。
- 5例冷冻前有疼痛性肿块,术后即刻缓解并持续整个随访期。
诊断标准与关键数值
- 所有操作在局部麻醉下完成且技术成功。
- 术前及术后1、3、6、12个月行临床和乳腺MRI评估。
临床应用与阅片要点
- 作者认为原发乳腺病灶冷冻消融似乎适合转移性患者的姑息治疗,尤其因其耐受性好、并发症率低并能提供局部或镇痛控制。
- 作者指出该姑息治疗在常规实践中可实施,能有效局部控制肿瘤并提供即刻和长期镇痛控制。
局限性
- 2例病灶40 mm和45 mm者随访期复发,第二次冷冻治疗未纳入本研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate safety, feasibility and efficacy of percutaneous cryoablation of breast tumours in patients with clinically stable metastatic breast cancer, and to compare the findings with reports on alternative procedures, namely surgery and local radiotherapy.
METHODS: 17 female patients (average age of 54.8 years ± 10.8; range 37-72) with primary breast tumour not surgically treated because of metastatic disease were included. Patients were treated for their primary lesion by percutaneous cryotherapy in period of stable disease. This minimally intervention was performed using ultrasound or CT scan guidance. All patients had clinical and breast-MRI evaluation before and at 1, 3, 6 and 12 months after the procedure.
RESULTS: All procedures were performed under local anaesthesia and technically successful. The mean largest diameter of the primary lesions was 16 ± 12 mm (size range 5-45 mm). In 15 patients, we obtained a complete regression of the primary breast lesion without recurrence during the follow-up period. Two patients with lesions measured at 40 and 45 mm had recurrence in follow up period. A second session of cryotherapy was performed for these 2 patients, not included in this study. Five patients had painful masses before cryotherapy. All were immediately relieved after the intervention and durably during all follow-up.
CONCLUSION: These results show that the cryoablation of primary breast lesions seems to be well suited to the palliative care of metastatic patients, particularly because of its good tolerance, low complication rate and ability to provide local or analgesic control. Advances in knowledge: Therapies are limited for these symptomatic patients at metastatic state of primary breast tumour. This study shows that cryoablation in palliative care is achievable in common practice, is effective in local control of the tumour and can provide immediate and long-term analgesic control.
引用
- Beji H, Pilleul F, Picard R, et al. Percutaneous cryoablation of breast tumours in patients with stable metastatic breast cancer: safety, feasibility and efficacy. Br J Radiol. 2018. PMID: 29243490. doi:10.1259/bjr.20170500
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。